Mechanisms of Integrin–Vascular Endothelial Growth Factor Receptor Cross-Activation in Angiogenesis
- 14 September 2007
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 101 (6) , 570-580
- https://doi.org/10.1161/circresaha.107.155655
Abstract
The functional responses of endothelial cells are dependent on signaling from peptide growth factors and the cellular adhesion receptors, integrins. These include cell adhesion, migration, and proliferation, which, in turn, are essential for more complex processes such as formation of the endothelial tube network during angiogenesis. This study identifies the molecular requirements for the cross-activation between β3 integrin and tyrosine kinase receptor 2 for vascular endothelial growth factor (VEGF) receptor (VEGFR-2) on endothelium. The relationship between VEGFR-2 and β3 integrin appears to be synergistic, because VEGFR-2 activation induces β3 integrin tyrosine phosphorylation, which, in turn, is crucial for VEGF-induced tyrosine phosphorylation of VEGFR-2. We demonstrate here that adhesion- and growth factor–induced β3 integrin tyrosine phosphorylation are directly mediated by c-Src. VEGF-stimulated recruitment and activation of c-Src and subsequent β3 integrin tyrosine phosphorylation are critical for interaction between VEGFR-2 and β3 integrin. Moreover, c-Src mediates growth factor–induced β3 integrin activation, ligand binding, β3 integrin-dependent cell adhesion, directional migration of endothelial cells, and initiation of angiogenic programming in endothelial cells. Thus, the present study determines the molecular mechanisms and consequences of the synergism between 2 cell surface receptor systems, growth factor receptor and integrins, and opens new avenues for the development of pro- and antiangiogenic strategies.Keywords
This publication has 30 references indexed in Scilit:
- Cooperation between VEGF and β3 integrin during cardiac vascular developmentBlood, 2006
- Integrin signaling is critical for pathological angiogenesisThe Journal of Experimental Medicine, 2006
- Antiangiogenic Therapy Decreases Integrin Expression in Normalized Tumor Blood VesselsCancer Research, 2006
- Angiogenesis in life, disease and medicineNature, 2005
- Molecular and mechanical synergy: cross-talk between integrins and growth factor receptors*1Cardiovascular Research, 2004
- Proximal, selective, and dynamic interactions between integrin αIIbβ3 and protein tyrosine kinases in living cellsThe Journal of cell biology, 2004
- β3 integrin phosphorylation is essential for Arp3 organization into leukocyte αVβ3-vitronectin adhesion contactsJournal of Cell Science, 2004
- IntegrinsCell, 2002
- Src family kinases are required for integrin but not PDGFR signal transductionThe EMBO Journal, 1999
- Requirement of Integrin β3 Tyrosine 747 for β3 Tyrosine Phosphorylation and Regulation of αvβ3 AvidityPublished by Elsevier ,1997